Stay updated on Lumateperone Adjunct in Major Depressive Disorder Clinical Trial

Sign up to get notified when there's something new on the Lumateperone Adjunct in Major Depressive Disorder Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lumateperone Adjunct in Major Depressive Disorder Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The study record for a completed Phase 3 trial of lumateperone as adjunctive treatment for major depressive disorder is displayed, including participant criteria, study design and outcomes, and locations. It also shows related publications, record dates, and study documents.
    Difference
    67%
    Check dated 2026-11-07T14:46:20.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page continues to display a 403 Forbidden error instead of the study record. The footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-31T15:25:46.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A site-wide notice announces updates and FAQs about NIH websites and a federal shift from the term “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T14:43:02.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site revision label in the footer changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T14:34:19.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The site footer revision label changes from v3.7.0 to v3.7.1 while the 403 error page remains otherwise unchanged.
    Difference
    0.2%
    Check dated 2026-10-10T14:36:03.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the study details. The page displays the site header and a minimal error message, indicating access is blocked.
    Difference
    17%
    Check dated 2026-09-19T19:03:26.000Z thumbnail image

Stay in the know with updates to Lumateperone Adjunct in Major Depressive Disorder Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lumateperone Adjunct in Major Depressive Disorder Clinical Trial page.